Adrian Yurkwich joined Silverfleet Capital in 2005, and is responsible for the firm’s investment activities in the healthcare sector. Adrian currently sits on the board of portfolio company, Aesica Pharmaceuticals and AGR.
Adrian has a breadth of experience in private equity, having worked at UBS Capital – where he became their youngest partner, Phoenix Equity Partners as well as Silverfleet Capital. Adrian started his career in the corporate restructuring department of Price Waterhouse.
Adrian is a chartered accountant and has a degree in Chemistry from the University of Bristol.